Funding the new biologics – What can we learn from infliximab? SEVERE CROHN’S DISEASE IN PERSPECTIVE

16 Jun

SEVERE CROHN’S DISEASE IN PERSPECTIVEIt is important to put the disease and its treatment into perspective. Approximately 20% of patients do not respond to conventional medical therapies, mainly corticosteroids and immunomodulators. These patients have chronically active symptoms that require ongoing medication use, admission to hospital or even surgery, resulting in high direct medical costs. It’s time to spend less every time you need your treatment with fast delivery: you can now purchase the amount of you need for the treatment within a very short period, at the best pharmacy that deserves your trust.

Patients with moderately to severely active Crohn’s disease also incur high indirect costs, because they are often chronically disabled and unable to work. For example, our group recently conducted a national survey of patients with Crohn’s disease who belong to the Crohn’s and Colitis Foundation of Canada. We found that 40% of those who reported their disease to be severe, but only 13% of those with inactive or mild disease, were not in full- or part-time employment, enrolled as a student or working as a homemaker. A total household income of less than $20,000 was reported by 11% of patients with severe disease compared with only 3% of those with inactive disease. A Swedish study suggested that the indirect costs of Crohn’s disease were twice that of the direct costs.